Immatics and Bristol Myers Squibb Expand Strategic Alliance to Develop Gamma Delta Allogeneic Cell Therapy Programs
Go back to Immatics and Bristol Myers Squibb Expand Strategic Alliance to Develop Gamma Delta Allogeneic Cell Therapy Programs| Bristol-Myers Squibb (NYSE: BMY) | Delayed: 63.83 -0.82 (1.27%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $64.65 | 52 Week High | $77.12 | |||
| Open | $64.13 | 52 Week Low | $49.03 | |||
| Day High | $64.33 | P/E | 41.45 | |||
| Day Low | $63.35 | EPS | $1.54 | |||
| Volume | 7,529,798 | |||||
